Skip to content

Net margin at other companies

Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
-76,423.3%-77,733pp
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
55.9%+35.7pp
Tango Therapeutics logo
Tango TherapeuticsTNGX
-188.2%-55.4pp
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
-52,939.7%-61,871pp
LQD
Liquidia CorporationLQDA
-176.2%-76.4pp
Revvity logo
RevvityRVTY
8.3%-2.1pp

Other financials

Income statement

See full
Revenue$3.0M-60.9%
Operating income-$78.6M+7.4%
Net income-$73.3M+4.9%
EPS (diluted)-$0.41+10.9%

Balance sheet

See full
Cash & equivalents$204.6M+119%
Total debt$31.6M-33.1%
Total equity$642.2M-10.9%
Total assets$699.6M-12.5%

Cash flow

See full
Operating cash flow-$51.1M+30.2%
CapEx$1.0K
Free cash flow-$44.9M+22.5%

Valuation

See full
Market cap$3.46B+300%
Enterprise value$3.29B+304%
P/S324.1×+212×

Profitability

See full
Operating margin-2,776.6%-820pp
FCF margin-1,536%-429pp

Returns & leverage

See full
Return on equity-40%-4.3pp
Debt / equity0.0×
Current ratio22.1×+2.2×

Where this comes from

Calculated from Relay Therapeutics, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s net margin?
Relay Therapeutics, Inc. (RLAY) reported net margin of -2,554.1% in Q1 2026.
How has Relay Therapeutics, Inc.'s net margin changed year-over-year?
Relay Therapeutics, Inc.'s net margin increased by 41.2% year-over-year, from -4,341.5% to -2,554.1%.
What is the long-term trend for Relay Therapeutics, Inc.'s net margin?
Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s net margin has grown at a -37.8% compound annual growth rate (CAGR), from -12,012.9% to -1,800.5%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.